Tamer I. Khayal - 13 Jul 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Commercial Officer
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 13 Jul 2023
Net transactions value: -$420,103
Form type: 4
Filing time: 17 Jul 2023, 16:31:04 UTC
Previous filing: 25 Apr 2023
Next filing: 19 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$48,000	+2,974	+21%	$16.14^*	17,349	13 Jul 2023	Direct	F1
transaction	TMDX	Common Stock	Sale	$267,809	-2,974	-17%	$90.05	14,375	13 Jul 2023	Direct	F1, F2, F3
transaction	TMDX	Common Stock	Sale	$200,294	-2,225	-13%	$90.02	14,776	13 Jul 2023	By the Khayal Family 2021 Irrevocable Trust	F4, F5
holding	TMDX	Common Stock						11,051	13 Jul 2023	By the Tamer Ibrahim Ahmed Khayal Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-2,974	-12%	$0.000000	21,249	13 Jul 2023	Common Stock	2,974	$16.14	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4	The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 12, 2022.
F5	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
F6	The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.